Status:
COMPLETED
Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
Lead Sponsor:
Clearside Biomedical, Inc.
Conditions:
Uveitis
Macular Edema
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The study is designed to evaluate the safety and efficacy of triamcinolone acetonide, CLS-TA, in subjects with macular edema following non-infectious uveitis. A single suprachoroidal injection of one ...
Detailed Description
This is a Phase 2, randomized, masked, multicenter study to assess the safety and efficacy of two different doses of CLS-TA in the treatment of subjects with macular edema following non-infectious uve...
Eligibility Criteria
Inclusion
- diagnosis of noninfectious uveitis
- diagnosis of macular edema associated with noninfectious uveitis
Exclusion
- any ocular trauma within the immediate 6 months prior to treatment
- any photocoagulation or cryotherapy in the 6 months prior to treatment
- any IVT injection of anti-VEGF treatment in the 2 months prior to treatment
- any eye diseases other than uveitis and ME that could compromise central visual acuity
- any previous suprachoroidal injection of triamcinolone acetonide in the study eye
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT02255032
Start Date
October 1 2014
End Date
January 1 2016
Last Update
February 8 2021
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Miami, Florida, United States, 33136
2
Atlanta, Georgia, United States, 30322
3
Chicago, Illinois, United States, 60611
4
Boston, Massachusetts, United States, 02114